Dear Colleagues,
Please find attached the link
|
|||||||||||||||||||||||||||||||||||||||||
Regards,
Dorina Pirgari
From: KURTSIKASHVILI, Giorgi
Sent: Thursday, March 25, 2021 6:52 AM
To: PIRGARI, Dorina
Cc: Ms T. Gabunia (tgabunia@moh.gov.ge)
Subject: RE: Access to Sinopharm and Sinovac dossiers for GEO NRA
Dear Dorina,
Just got confirmation from the MoH to have a meeting at 11:00 CPH (14:00 Tbilisi) time.
First DM may also join to the meeting.
If this still ok for you, please send zoom link.
Thank you very much in advance.
Best regards,
Giorgi
From: PIRGARI, Dorina <pirgarid@who.int>
Sent: Tuesday, March 23, 2021 10:24 PM
To: Tamar Kirvalidze (tkirvalidze@moh.gov.ge) <tkirvalidze@moh.gov.ge>
Cc: KURTSIKASHVILI, Giorgi <kurtsikashvilig@who.int>
Subject: RE: Access to Sinopharm and Sinovac dossiers for GEO NRA
Importance: High
Dear Tamar,
Regarding the below e-mail please kindly let me know if it is possible for us to organse a call tomorrow,
Wednesday 24 March 2021 at 10:00 am CPH time or Thursday 25 March 2021 from 9:00 am to 12pm
Please advise what time works better with you and I will send you a ZOOM link.
Thank you
Regards,
Dorina Pirgari
From: PIRGARI, Dorina
Sent: Tuesday, March 23, 2021 7:21 PM
To: KURTSIKASHVILI, Giorgi <kurtsikashvilig@who.int>
Cc: BENES, Oleg <beneso@who.int>; DOMENTE, Silviu <domentes@who.int>; Dr A. Gamkrelidze (a.gamkrelidze@ncdc.ge) <a.gamkrelidze@ncdc.ge>;
Tamar Kirvalidze (tkirvalidze@moh.gov.ge) <tkirvalidze@moh.gov.ge>
Subject: RE: Access to Sinopharm and Sinovac dossiers for GEO NRA
Dear Giorgi,
Thank you for your e-mail.
Sinovac and Sinopharm are in the pipeline to get an emergency use listing from WHO. At the moment we are still awaiting the final information to be received from the manufacturer. As soon as the info will be received we will inform you
and the NRA focal point for the EUL will have access to the dossier.
I will schedule a meeting with the NRA tomorrow to discuss in detail how to request access in advance (meaning to sign the CDA) so GEO will get access as soon as the products are listed.
On the question related to AEFI, detailed information will be provided when the vaccine will get emergency approval by WHO.
Thank you
Regards,
Dorina Pirgari
From: KURTSIKASHVILI, Giorgi <kurtsikashvilig@who.int>
Sent: Friday, March 19, 2021 5:11 PM
To: PIRGARI, Dorina <pirgarid@who.int>
Cc: BENES, Oleg <beneso@who.int>; DOMENTE, Silviu <domentes@who.int>; Dr A. Gamkrelidze (a.gamkrelidze@ncdc.ge) <a.gamkrelidze@ncdc.ge>;
Tamar Kirvalidze (tkirvalidze@moh.gov.ge) <tkirvalidze@moh.gov.ge>
Subject: Access to Sinopharm and Sinovac dossiers for GEO NRA
Importance: High
Dear Dorina,
As we just discussed with Oleg, dossiers of Sinopharm and Sinovac vaccines might be accessible for country NRAs. Could you please kindly let us know if this is the case? And if so, is it possible to help get such access for GEO NRA?
Country may receive Sinopharm by bilateral agreement and Sinovac also might be donated, so this information is critically important for country to have detailed information about vaccine safety and efficacy in advance. If process of granting
access takes some time, it would be good to initiate it now.
Main question is regarding so many “very frequent” AEFIs for AZ among vaccinated individuals – how such AEFIs are expected in inactivated vaccines, like Sinopharm and Sinovac. If you also have provide some information on that, it would
be most welcomed 😊
Thank you very much in advance!
Best regards,
Giorgi
--
Giorgi Kurtsikashvili, M.D.
National Officer
WHO Country Office in Georgia
Office location: 81 Vasil Barnov Street, 0179 Tbilisi, Georgia
Mailing address: UN House, 9 Rapiel Eristavi Street, 0179 Tbilisi, Georgia
GPN.: 74214
Tel.: + 995 32 299 80 73
Mobile: +995 599 76 44 43
mailto:kurtsikashvilig@who.int
